Ex-GSK Lawyer Faces New Obstruction Indictment
Prosecutors have reindicted a former GlaxoSmithKline PLC attorney for allegedly lying to health regulators about the marketing of the antidepressant Wellbutrin, three weeks after a judge dismissed an earlier indictment for...To view the full article, register now.
Already a subscriber? Click here to view full article